|
| 产品描述 |
| ARRY-382 is a small molecule and orally available inhibitor of colony-stimulating factor-1 receptor (CSF1R; cFMS) with potential antineoplastic activity. cFMS tyrosine kinase inhibitor ARRY-382 binds to and inhibits the activity of cFMS. By preventing colony-stimulating factor-1 (CSF-1)-cFMS signaling, this agent may inhibit tumor cell proliferation in cFMS-overexpressing tumor cells. |
| 化学结构 |
 |
| 化学名称 |
| N-(3-cyclopropyl-l-((6-methylpyridin-2-yl)methyl)-lH-indazol-4-yl)-7-(2-(4- methylpiperazin-l-yl)ethoxy)imidazo[l,2-a]pyridine-3-carboxamide |
| 基本信息 |
产品编号:XM783
产品名称:ARRY-382
别名:ARRY-382, ARRY382
CAS#:1313407-95-2
分子式:C32H36N8O2
分子量:564.69
纯度:>98%
|
| 物化性质 |
外观: 固体粉末
纯度: >98%
运输信息: 非危险化学品，适于常温或冰袋运输。
储存条件: 低温，干燥，避光。
溶解性: 溶于DMSO, 不溶于水
储存期限:3年 -20℃固体储存
2 年 -80℃ 溶液储存 |
该产品只供科研使用，不能给病人提供。
|
|
|
